Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Illinois at Chicago
Beth Israel Deaconess Medical Center
University of Chicago
Beth Israel Deaconess Medical Center
Indiana University
Texas Oncology Cancer Center
Baylor College of Medicine